Replies to post #74080 on DNAprint Genomics (DNAG)

[dgplexus]

The potential upside far outweighs any potential loss. I was previously bought in at an average price of .0074, now I doubled that, buying 2 million more shares at .0042, making my average buy-in price .0058. Remember, "buy low, sell high," it's not the norm to "buy lowest, sell highest" (though everyone would want to do that, of course.) And there is no loss if the stock is not sold at a loss. I'm holding because I think the stock will most likely increase in price, FAR above my averaged buy-in price of .0058.